Sanjay Mohanty

Dr. Sanjay Mohanty

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
SMSanjay Mohanty
Sanjay Mohanty
AGAnna Gillio
Anna Gillio
HLHeidi Lindroth
Heidi Lindroth
DODamaris Ortiz
Damaris Ortiz
EHEmma Holler
Emma Holler
BZBen Zarzaur
Ben Zarzaur

28 November 2024 in The American Journal of Surgery
Verified
Journal Article
Open access
TRTyler P. Robinson
Tyler P. Robinson
KKKristen Kaiser
Kristen Kaiser
MLMeghan Lark
Meghan Lark
BRBrian Ruedinger
Brian Ruedinger
BRBruce W. Robb
Bruce W. Robb
SMSanjay Mohanty
Sanjay Mohanty
The National Comprehensive Cancer Care Network (NCCN) provides recommendations for patients with colorectal cancer. Concordance with evidence-based guidelines improves outcomes. Our objectives were to 1) examine rates of guideline non-concordance in a large vertically integrated health system; 2) examine factors associated with non-concordant care, and 3) identify geographical patterns of non-concordant care. Colorectal cancer patients were identified from a single-state 16 hospital health-system cancer registry diagnosed between 2011 and 2021. We defined major (MAJ) and minor (MIN) quality indicators of guideline-concordance based on NCCN guidelines. Regression methods were used to identify predictors of major quality criteria non-concordance. County-level mapping was used to identify geographical locations of the highest rates of non-concordance. Overall, 2324 patients with colon and rectal cancer were analyzed. There was a complete guideline concordance (an absence of guideline non-concordance) rate of 24.7​% (n ​= ​573), MIN only guideline non-concordance rate of 63.3​% (n ​= ​1471), and MAJ non-concordance rate of 12.4​% (n ​= ​280). Predictors of MAJ non-concordance for colon cancer were stage, >1 Charleson-Deyo Score, >60 days from diagnosis to treatment, and >1 hospital network used for care. Predictors of MAJ non-concordance for rectal cancer were >60 days from diagnosis to treatment, and >1 facility used for care. Marion county had the highest rates of non-concordance for colon and rectal cancer. The majority of colon and rectal cancer patients in a large health system received guideline concordant major quality indicators, however 12​% of patients do not. An identifiable geographical location with the highest rates of non-concordance and its associated factors serves as a target for future quality improvement.

1 November 2020 in The American Journal of Surgery
Verified
Journal Article
Closed access
PDF file
RHRebecca L. Hoffman
Rebecca L. Hoffman
PBPhilip S. Bauer
Philip S. Bauer
TCTiffany Chan
Tiffany Chan
SMSanjay Mohanty
Sanjay Mohanty
SHSteven Hunt
Steven Hunt
RSRadhika Smith
Radhika Smith

6 October 2022 in JMIR Cancer
Verified
Journal Article
Open access
NVNimish Valvi
Nimish Valvi
HPHetvee Patel
Hetvee Patel
GBGiorgos Bakoyannis
Giorgos Bakoyannis
DHDavid A Haggstrom
David A Haggstrom
SMSanjay Mohanty
Sanjay Mohanty
BDBrian E Dixon
Brian E Dixon
Background: Prior studies, generally conducted at single centers with small sample sizes, found that individuals with cancer experience more severe outcomes due to COVID-19, caused by SARS-CoV-2 infection. Although early examinations revealed greater risk of severe outcomes for patients with cancer, the magnitude of the increased risk remains unclear. Furthermore, prior studies were not typically performed using population-level data, especially those in the United States. Given robust prevention measures (eg, vaccines) are available for populations, examining the increased risk of patients with cancer due to SARS-CoV-2 infection using robust population-level analyses of electronic medical records is warranted. Objective: The aim of this paper is to evaluate the association between SARS-CoV-2 infection and all-cause mortality among recently diagnosed adults with cancer. Methods: We conducted a retrospective cohort study of newly diagnosed adults with cancer between January 1, 2019, and December 31, 2020, using electronic health records linked to a statewide SARS-CoV-2 testing database. The primary outcome was all-cause mortality. We used the Kaplan-Meier estimator to estimate survival during the COVID-19 period (January 15, 2020, to December 31, 2020). We further modeled SARS-CoV-2 infection as a time-dependent exposure (immortal time bias) in a multivariable Cox proportional hazards model adjusting for clinical and demographic variables to estimate the hazard ratios (HRs) among newly diagnosed adults with cancer. Sensitivity analyses were conducted using the above methods among individuals with cancer-staging information. Results: During the study period, 41,924 adults were identified with newly diagnosed cancer, of which 2894 (6.9%) tested positive for SARS-CoV-2. The population consisted of White (n=32,867, 78.4%), Black (n=2671, 6.4%), Hispanic (n=832, 2.0%), and other (n=5554, 13.2%) racial backgrounds, with both male (n=21,354, 50.9%) and female (n=20,570, 49.1%) individuals. In the COVID-19 period analysis, after adjusting for age, sex, race or ethnicity, comorbidities, cancer type, and region, the risk of death increased by 91% (adjusted HR 1.91; 95% CI 1.76-2.09) compared to the pre–COVID-19 period (January 1, 2019, to January 14, 2020) after adjusting for other covariates. In the adjusted time-dependent analysis, SARS-CoV-2 infection was associated with an increase in all-cause mortality (adjusted HR 6.91; 95% CI 6.06-7.89). Mortality increased 2.5 times among adults aged 65 years and older (adjusted HR 2.74; 95% CI 2.26-3.31) compared to adults 18-44 years old, among male (adjusted HR 1.23; 95% CI 1.14-1.32) compared to female individuals, and those with ≥2 chronic conditions (adjusted HR 2.12; 95% CI 1.94-2.31) compared to those with no comorbidities. Risk of mortality was 9% higher in the rural population (adjusted HR 1.09; 95% CI 1.01-1.18) compared to adult urban residents. Conclusions: The findings highlight increased risk of death is associated with SARS-CoV-2 infection among patients with a recent diagnosis of cancer. Elevated risk underscores the importance of adhering to social distancing, mask adherence, vaccination, and regular testing among the adult cancer population.

20 May 2015 in Surgery
Verified
Journal Article
Closed access
PDF file
SMSanjay Mohanty
Sanjay Mohanty
JPJennifer Paruch
Jennifer Paruch
KBKarl Y. Bilimoria
Karl Y. Bilimoria
MCMark Cohen
Mark Cohen
VSVivian E. Strong
Vivian E. Strong
SWSharon M. Weber
Sharon M. Weber

5 February 2023 in Clinics in Colon and Rectal Surgery
Verified
Journal Article
Closed access
PDF file
CFCyrus Ali Feizpour
Cyrus Ali Feizpour
ATAnita Turk
Anita Turk
SMSanjay Mohanty
Sanjay Mohanty
With improvements across the colorectal cancer care continuum, from screening and earlier detection to better systemic options, patients are living longer with the disease. Given these improvements over the last several decades, quality of life outcomes have become important components when evaluating treatment efficacy and adverse effects. This article reviews quality of life measurement generally, discusses tools currently being used in colorectal cancer patients, and reviews outcomes following both surgical and nonsurgical management from clinical trials, observational studies, and meta-analyses.